Skip to main content

Table 1 Patient characteristics, symptoms, treatment, and outcomes

From: Coronavirus disease 2019 outcomes in heart transplant recipients: a single-center case series

Demographics

No.

Total, no.

13

Age, mean (years)

44.3

Male

9

Time, post-transplant, mean (years)

6.4

Hypertension

3

Diabetes mellitus

3

Chronic kidney diseasea

2

Maintenance immunosuppression

 

 Total, no.

13

 Tacrolimus

10

 Cyclosporine

3

 Mycophenolate mofetil

6

 Mycophenolate sodium

7

 Methylprednisolone

5

No. of immunosuppressive medications

 

 3

13

Symptoms

 

 Total, no.

11

 Asymptomatic

2

 Fever

6

 Myalgia or malaise

5

 Shortness of breath or cough

7

 Gastrointestinal symptoms

3

 Treatment

 

 Total inpatients and outpatients, no.

13

 Remdesivir

9

 Tocilizumab

1

 Interferon beta

1

 Intravenous immunoglobulin

2

 Dexamethasone

7

 Reduction in immunosuppression medications

8

 Mycophenolate mofetil held

9

 Supplemental oxygen

6

Outcome

 

 Total, no.

13

 Overall survival

12

 Overall mortality

1

Hospitalized

10

 In-hospital mortality

1

 ICU admission

2

 Discharged

12

 Managed as outpatient

3

 Clinically overt rejection

0

  1. aDefined by a glomerular filtration rate less than 30